Search research articles

Related Concept Videos

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Diabetes Mellitus: Introduction

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Urate-induced epigenetic modifications in myeloid cells.

Arthritis research & therapy·2021

Same author

Yap regulates skeletal muscle fatty acid oxidation and adiposity in metabolic disease.

Nature communications·2021

Same author

Safe management of full-capacity live/mass events in COVID-19 will require mathematical, epidemiological and economic modelling.

Journal of the Royal Society of Medicine·2021

Same author

The circadian syndrome predicts cardiovascular disease better than metabolic syndrome in Chinese adults.

Journal of internal medicine·2020

Same author

The efficacy of microlearning in improving self-care capability: a systematic review of the literature.

Public health·2020

Same author

The Circadian Syndrome: is the Metabolic Syndrome and much more!

Journal of internal medicine·2019

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: May 14, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Epigenetic changes in diabetes.

S T Keating¹, A El-Osta

¹Epigenetics in Human Health and Disease Laboratory, Baker IDI Heart & Diabetes Institute, The Alfred Medical Research and Education Precinct, Melbourne, Victoria 3004, Australia.

Clinical Genetics

|February 13, 2013

Summary

This summary is machine-generated.

Epigenetics plays a crucial role in diabetes development and complications, influencing gene expression in response to environmental factors. Understanding these epigenetic changes offers new therapeutic avenues for managing diabetes and its long-term effects.

More Related Videos

Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death

Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death

Published on: December 21, 2016

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Related Experiment Videos

Last Updated: May 14, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death

Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death

Published on: December 21, 2016

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Area of Science:

Endocrinology
Genetics
Molecular Biology

Background:

Diabetes mellitus is a complex, multifactorial disease influenced by genetics and environmental factors.
Emerging evidence highlights the significant role of epigenetics in diabetes pathogenesis.
Epigenetic modifications can alter gene expression in response to metabolic and environmental cues.

Purpose of the Study:

To explore the contribution of epigenetic mechanisms to diabetes development and progression.
To investigate how epigenetic changes influence susceptibility to diabetic complications.
To understand the molecular basis of metabolic memory in diabetes.

Main Methods:

Review of epidemiological and experimental animal studies.
Analysis of epigenetic processes at the chromatin level.
Investigation of gene expression changes in response to metabolic state and hyperglycemia.

Main Results:

Epigenetic processes mediate the impact of environmental factors on diabetes-related gene expression.
Epigenetic mechanisms contribute to both the predisposition to diabetes and the development of its complications.
Early hyperglycemia exposure can induce persistent epigenetic changes, leading to a 'metabolic memory' of complications.

Conclusions:

Epigenetic modifications are critical in diabetes pathogenesis and the development of long-term complications.
Understanding these molecular events is key to developing novel therapeutic strategies.
Targeting epigenetic pathways may offer new ways to prevent, reverse, or slow diabetic complications.